United States Food and Drug Administration
-
Lupin receives tentative approval from US FDA for Migalastat caps
The product will be manufactured at Lupin’s Goa facility in India Lupin has received tentative approval from the United States…
Read More » -
Lupin bags US FDA approval for Glycopyrrolate injection
The first approval from Lupin’s injectable facility in Nagpur Lupin has received approval from the United States Food and Drug…
Read More » -
Lupin bags USFDA approval for Efinaconazole Topical Solution
The product will be manufactured at Lupin’s facility in Pithampur Lupin has received approval from the United States Food and…
Read More » -
Lupin bags US FDA approval for Arformoterol Tartrate Inhalation Solution
The drug is indicated for the long-term maintenance treatment of bronchoconstriction in patients with COPD Lupin has received approval from…
Read More » -
Gland Pharma gets US FDA nod for generic Foscarnet Sodium injection
The injection is indicated for the treatment of cytomegalovirus retinitis in patients with AIDS Gland Pharma has received approval from…
Read More » -
Lupin launches Posaconazole delayed-release tablets
Posaconazole delayed-release tablet is a generic equivalent of Noxafil delayed-release tablet, of Merck Sharp & Dohme Corp Lupin has launched…
Read More »